Company Tatva Chintan Pharma Chem Limited Bombay S.E.
Equities
TATVA
INE0GK401011
Specialty Chemicals
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,172 INR | +0.57% |
|
+0.70% | -26.87% |
Business Summary
Number of employees: 608
Sales per Business
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Phase Transfer Catalysts
34.0
%
| 980 | 22.7 % | 1,432 | 34.0 % | +46.09% |
Pharmaceutical and Agrochemical Intermediates and Other Specialty Chemicals
31.7
%
| 1,028 | 23.8 % | 1,335 | 31.7 % | +29.93% |
Structure Directing Agents
30.3
%
| 2,248 | 52.1 % | 1,276 | 30.3 % | -43.23% |
Electrolyte Salts
3.9
%
| 57 | 1.3 % | 165 | 3.9 % | +190.92% |
Sales per region
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
International
72.3
%
| 3,405 | 78.9 % | 3,042 | 72.3 % | -10.64% |
India
27.7
%
| 908 | 21.1 % | 1,167 | 27.7 % | +28.44% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 51 | 96-06-11 | |
Ashok Bothra
DFI | Director of Finance/CFO | - | 21-12-02 |
Chief Administrative Officer | - | 15-11-20 | |
Chief Operating Officer | - | 17-10-11 | |
Ajay Singh Rawat
CTO | Chief Tech/Sci/R&D Officer | - | 19-07-04 |
Compliance Officer | - | 22-01-16 | |
Rakesh Poonia
PRN | Corporate Officer/Principal | - | 06-11-16 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 64 | 21-02-26 | |
Chief Executive Officer | 51 | 96-06-11 | |
Director/Board Member | 52 | 96-06-11 | |
Director/Board Member | 50 | 96-06-11 | |
Director/Board Member | 71 | 21-02-26 | |
Director/Board Member | 52 | 21-02-26 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 23,392,055 | 6,545,097 ( 27.98 %) | 0 | 27.98 % |
Company contact information
Tatva Chintan Pharma Chem Ltd.
GIDC Estate Plot No 502/17
393002, Ankleshwar
+91 75 7484 8533
http://www.tatvachintan.com![address Tatva Chintan Pharma Chem Limited(TATVA)](https://cdn.zonebourse.com/static/address/125324724.png)
Sales per Business
Sales per region
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.35% | 70.02B | |
-4.09% | 47.08B | |
+21.47% | 44.25B | |
+35.36% | 29.07B | |
+5.36% | 18.91B | |
+12.76% | 17.15B | |
-5.28% | 16.11B | |
-28.83% | 14.28B | |
-30.22% | 12.17B |
- Stock Market
- Equities
- TATVA Stock
- TATVA Stock
- Company Tatva Chintan Pharma Chem Limited